ACELRX PHARMACEUTICALS INC ACRX
COM · Common Stock · CUSIP 00444T100
1
institutional holders
-56 vs Q3 2022
1.8k
shares reported held*
$4.1kreported value*
0 new
0 added
1 reduced
55 sold out
net sold ≈ $41.2m (-18.2m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.26.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 57 |
| Q4 2022 | 1 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2022 | $2.0k | $0 | 0.00 |
| Q4 2022 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| Rock Springs Capital Management LP | Sold out | -6.3m |
| VANGUARD GROUP INC | Sold out | -4.6m |
| BlackRock Inc. | Sold out | -1.9m |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -1.2m |
| Values First Advisors, Inc. | Sold out | -794.2k |
| STATE STREET CORP | Sold out | -443.7k |
| Texas Capital Bank Wealth Management Services Inc | Sold out | -430.0k |
| TANG CAPITAL MANAGEMENT LLC | Sold out | -388.5k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Sold out | -253.3k |
| NORTHERN TRUST CORP | Sold out | -219.3k |
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| CoreCap Advisors, LLC 0.00% of their portfolio | 1.8k $4.1k | Reduced -34.2k |